Hyperbaric Oxygen Therapy Versus Intravenous Thrombolysis in the Treatment of Central Retinal Artery Occlusion: A Systematic Review and Meta-Analysis
Journal of Clinical Medicine · 30.03.2026 · 15 (7) · 2628
DOI: 10.3390/jcm15072628 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Journal of Clinical Medicine, online erschienen am 30.03.2026. Verfasst von Anas Bakdalieh und 3 weiteren Autor:innen. Beteiligte Einrichtung: College of Medicine, Northeast Ohio Medical University, Rootstown, OH 44272, USA. Die Arbeit nennt 45 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NEI NIH HHS, Case Western Reserve University, National Institute of Health.
Abstract (Originalsprache)
Background
Central retinal artery occlusion (CRAO) causes sudden, often profound monocular vision loss. We compared the efficacy and safety of hyperbaric oxygen therapy (HBOT) versus intravenous thrombolysis (IVT) using a systematic review and meta-analysis.
Methods
Following PRISMA 2020 guidance, we searched PubMed, Cochrane Library, Web of Science, and VHL from inception to 27 May 2025, screened records in duplicate, and synthesized visual outcomes (best-corrected visual acuity [BCVA], logMAR), onset-to-treatment time, and adverse events using random-effects models.
Results
Twenty-five observational studies (781 patients; 557 HBOT eyes, 225 IVT eyes) met inclusion. Both HBOT and IVT were associated with significant improvements in BCVA (HBOT: MD −0.57 logMAR; IVT: MD −0.53 logMAR). Clinically meaningful improvement occurred in 45.8% after HBOT and 42.0% after IVT. Adverse event rates were similar (HBOT 11.3%; IVT 10.2%) but differed in type (ear barotrauma with HBOT; hemorrhagic events with IVT).
Conclusions
HBOT and IVT both improve visual outcomes in CRAO. Differences in adverse event profiles and substantial heterogeneity among IVT studies underscore the need for adequately powered comparative trials and standardized treatment pathways. Registration: Not prospectively registered; PRISMA 2020 checklist is provided.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- College of Medicine, Northeast Ohio Medical University, Rootstown, OH 44272, USA.
- College of Health Solutions, Arizona State University, Phoenix, AZ 85004, USA.
- Department of Statistics, University of Pretoria, Pretoria 0002, South Africa.
- Department of Ophthalmology and Visual Sciences, University Hospitals Eye Institute, Case Western Reserve University, Cleveland, OH 44106, USA.
- Cole Eye Institute, Cleveland Clinic Foundation, Cleveland, OH 44106, USA.
- Department of Ophthalmology, Cleveland Clinic Lerner College of Medicine of Case Western Reserve University, Cleveland, OH 44195, USA.
ORCID-Profile: Anas Bakdalieh, Ding-Geng Chen
Förderung
- NEI NIH HHS
- Case Western Reserve University
- National Institute of Health
Zitieren
APA
Bakdalieh, A., Siddiqui, D., Chen, D. G., & Yu, M. (2026). Hyperbaric Oxygen Therapy Versus Intravenous Thrombolysis in the Treatment of Central Retinal Artery Occlusion: A Systematic Review and Meta-Analysis. Journal of Clinical Medicine, 15(7), 2628. https://doi.org/10.3390/jcm15072628
Vancouver
Bakdalieh A, Siddiqui D, Chen DG, Yu M. Hyperbaric Oxygen Therapy Versus Intravenous Thrombolysis in the Treatment of Central Retinal Artery Occlusion: A Systematic Review and Meta-Analysis. Journal of Clinical Medicine. 2026;15(7):2628. doi:10.3390/jcm15072628
BibTeX
@article{Bakdalieh2026,
author = {Bakdalieh, Anas and Siddiqui, Dawood and Chen, Ding-Geng and Yu, Minzhong},
title = {Hyperbaric Oxygen Therapy Versus Intravenous Thrombolysis in the Treatment of Central Retinal Artery Occlusion: A Systematic Review and Meta-Analysis},
journal = {Journal of Clinical Medicine},
year = {2026},
volume = {15},
number = {7},
pages = {2628},
doi = {10.3390/jcm15072628}
}
EUVIMED